{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:40:22Z","timestamp":1793313622258,"version":"4.5.0"},"reference-count":40,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2023,3,14]]},"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pneumonia is common among older adults and often recurrent. Several studies have been conducted on the risk factors for pneumonia; however, little is known about the risk factors for recurrent pneumonia. This study aimed to identify the risk factors for developing recurrent pneumonia among older adults and to investigate methods of prevention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analysed the data of 256 patients aged 75\u2005years or older who were admitted for pneumonia between June 2014 and May 2017. Moreover, we reviewed the medical records for the subsequent 3\u2005years and defined the readmission caused by pneumonia as recurrent pneumonia. Risk factors for recurrent pneumonia were analysed using multivariable logistic regression analysis. Differences in the recurrence rate based on the types and use of hypnotics were also evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 256 patients, 90 (35.2%) experienced recurrent pneumonia. A low body mass index (OR: 0.91; 95% CI: 0.83\u20120.99), history of pneumonia (OR: 2.71; 95% CI: 1.23\u20126.13), lung disease as a comorbidity (OR: 4.73; 95% CI: 2.13\u201211.60), taking hypnotics (OR: 2.16; 95% CI: 1.18\u20124.01) and taking histamine-1 receptor antagonist (H1RA) (OR: 2.38; 95% CI: 1.07\u20125.39) were risk factors. Patients taking benzodiazepine as hypnotics were more likely to experience recurrent pneumonia than patients not taking hypnotics (OR: 2.29; 95% CI: 1.25\u20134.18).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We identified several risk factors for recurrent pneumonia. Among them, restricting the use of H1RA and hypnotics, in particular benzodiazepines, may be useful in preventing the recurrence of pneumonia in adults aged 75\u2005years or older.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00516-2022","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T15:22:10Z","timestamp":1680189730000},"page":"00516-2022","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Risk factors and interventions for developing recurrent pneumonia in older adults"],"prefix":"10.1183","volume":"9","author":[{"given":"Kazufumi","family":"Takada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3444-0536","authenticated-orcid":false,"given":"Atsushi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Takaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyo","family":"Tamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiya","family":"Takai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"2024101711563936000_9.3.00516-2022.1","unstructured":"World Health Organization . The top 10 causes of death. www.who.int\/en\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death Date last updated: 9 December 2020; Date last accessed: 5 July 2022."},{"key":"2024101711563936000_9.3.00516-2022.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204282"},{"key":"2024101711563936000_9.3.00516-2022.3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122247"},{"key":"2024101711563936000_9.3.00516-2022.4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.arbres.2014.11.009","article-title":"Age group analysis of psychological, physical and functional deterioration in patients hospitalized for pneumonia","volume":"51","author":"Mart\u00edn-Salvador","year":"2015","journal-title":"Arch Bronconeumol"},{"key":"2024101711563936000_9.3.00516-2022.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1004"},{"key":"2024101711563936000_9.3.00516-2022.6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy312"},{"key":"2024101711563936000_9.3.00516-2022.7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50106.x"},{"key":"2024101711563936000_9.3.00516-2022.8","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91473-L"},{"key":"2024101711563936000_9.3.00516-2022.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0359-1"},{"key":"2024101711563936000_9.3.00516-2022.10","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-014-0229-6"},{"key":"2024101711563936000_9.3.00516-2022.11","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2147\/CIA.S150499","article-title":"Impact of the number of aspiration risk factors on mortality and recurrence in community-onset pneumonia","volume":"12","author":"Noguchi","year":"2017","journal-title":"Clin Interv Aging"},{"key":"2024101711563936000_9.3.00516-2022.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02918.x"},{"key":"2024101711563936000_9.3.00516-2022.13","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.121434"},{"key":"2024101711563936000_9.3.00516-2022.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2008.01329.x"},{"key":"2024101711563936000_9.3.00516-2022.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2012.11.001"},{"key":"2024101711563936000_9.3.00516-2022.16","doi-asserted-by":"publisher","DOI":"10.2188\/jea.17.194"},{"key":"2024101711563936000_9.3.00516-2022.17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3164\/jcbn.20-85","article-title":"Risk for prolonged hospitalization and mortality in aged community acquired pneumonia patients: a retrospective study in Japan","volume":"67","author":"Matsuo","year":"2020","journal-title":"J Clin Biochem Nutr"},{"key":"2024101711563936000_9.3.00516-2022.18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1750-2659.2011.00262.x","article-title":"Body mass index and the incidence of influenza-associated pneumonia in a UK primary care cohort","volume":"6","author":"Blumentals","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"key":"2024101711563936000_9.3.00516-2022.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52556.x"},{"key":"2024101711563936000_9.3.00516-2022.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00095807"},{"key":"2024101711563936000_9.3.00516-2022.21","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp09X472629"},{"key":"2024101711563936000_9.3.00516-2022.22","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.18.2717"},{"key":"2024101711563936000_9.3.00516-2022.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2446-0"},{"key":"2024101711563936000_9.3.00516-2022.24","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15767"},{"key":"2024101711563936000_9.3.00516-2022.25","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200317110-00004"},{"key":"2024101711563936000_9.3.00516-2022.26","first-page":"90","article-title":"Side effects of treatment with benzodiazepines","volume":"22","author":"Uzun","year":"2010","journal-title":"Psychiatr Danub"},{"key":"2024101711563936000_9.3.00516-2022.27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/arclin\/acx120","article-title":"The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis","volume":"33","author":"Crowe","year":"2018","journal-title":"Arch Clin Neuropsychol"},{"key":"2024101711563936000_9.3.00516-2022.28","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.3914"},{"key":"2024101711563936000_9.3.00516-2022.29","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2010.300014"},{"key":"2024101711563936000_9.3.00516-2022.30","doi-asserted-by":"publisher","DOI":"10.2188\/jea.10.79"},{"key":"2024101711563936000_9.3.00516-2022.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2006.10.009"},{"key":"2024101711563936000_9.3.00516-2022.32","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202374"},{"key":"2024101711563936000_9.3.00516-2022.33","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160126"},{"key":"2024101711563936000_9.3.00516-2022.34","first-page":"932","article-title":"The risk of pneumonia in older adults using nonbenzodiazepine hypnotics","volume":"22","author":"Jung","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"2024101711563936000_9.3.00516-2022.35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chest.2017.07.030","article-title":"The use of benzodiazepine receptor agonists and the risk of hospitalization for pneumonia: a nationwide population-based nested case-control study","volume":"153","author":"Chen","year":"2018","journal-title":"Chest"},{"key":"2024101711563936000_9.3.00516-2022.36","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/pds.4028","article-title":"The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK primary care data","volume":"25","author":"Nakafero","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024101711563936000_9.3.00516-2022.37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128004"},{"key":"2024101711563936000_9.3.00516-2022.38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.722"},{"key":"2024101711563936000_9.3.00516-2022.39","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2011.562889"},{"key":"2024101711563936000_9.3.00516-2022.40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1556\/2060.2020.00019","article-title":"Salivary dysfunction caused by medication usage","volume":"107","author":"Einhorn","year":"2020","journal-title":"Physiol Int"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00516-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:24:42Z","timestamp":1740374682000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00516-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,5,2]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1183\/23120541.00516-2022"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00516-2022","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]}}}